Home › Funds › Athos Capital Ltd › TECH

Athos Capital Ltd position in TECH

BIO-TECHNE CORP · Health Care

Athos Capital Ltd reported holding 102,100 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 4.24% of its reported portfolio and ranking #6 among its reported holdings. Athos Capital Ltd has disclosed TECH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)102.10K sh
Reported value held$7.40M
Portfolio Weight4.24%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Athos Capital Ltd's TECH position evolved

Athos Capital Ltd first disclosed a stake in TECH in Q2 2026 at 100,000 shares (US$7.1M). The position peaked in Q3 2026 at 102,100 shares, worth US$7.4M. Across 2 filings, Athos Capital Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 102,100 shares valued at US$7.4M — an increase of 2,100 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 100.00K $7.07M New
Q3 2026 102.10K $7.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 27 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has Athos Capital Ltd held TECH?

Athos Capital Ltd has disclosed TECH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Athos Capital Ltd's current position in TECH?

As of Q3 2026, Athos Capital Ltd holds 102.10K shares of TECH (BIO-TECHNE CORP), valued at $7.40M, representing 4.24% of its reported portfolio and ranking #6.

Has Athos Capital Ltd been buying or selling TECH?

In the latest 13F filing (Q3 2026), Athos Capital Ltd increased its position in TECH. The position peaked in Q3 2026 at 102.10K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.